摘要 |
The present invention inter alia provides a method, and uses thereof, of predicting statin-induced muscle toxicity orits complications, such as myalgia, myopathy and rhabdomyolysis, by detecting the lipid concentrations or lipid-lipid concentration ratios of a biological sample and comparing them to a control. This method has identified lipid markers that are more specific and sensitive in detecting these statin-induced muscle toxicity than the currently utilized clinical markers. Also provided is an antibody towards said lipids, and the use thereof for predicting, diagnosing, statin-induced muscle toxicity. The invention additionally relates to kits comprising lipids and/or an antibody thereto, for use in the prediction and/or diagnosis of statin-induced muscle toxicity. |
申请人 |
ZORA BIOSCIENCES OY;LAAKSONEN, REIJO;EKROOS, KIM;HURME, REINI;JAENIS, MINNA;KATAINEN, RIIKKA;TARASOV, KIRILL |
发明人 |
LAAKSONEN, REIJO;EKROOS, KIM;HURME, REINI;JAENIS, MINNA;KATAINEN, RIIKKA;TARASOV, KIRILL |